211 related articles for article (PubMed ID: 12097147)
41. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
42. Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells.
Wang W; Mariani FV; Harland RM; Luo K
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14394-9. PubMed ID: 11121043
[TBL] [Abstract][Full Text] [Related]
43. TGF-beta signaling by Smad proteins.
Miyazono K
Cytokine Growth Factor Rev; 2000; 11(1-2):15-22. PubMed ID: 10708949
[TBL] [Abstract][Full Text] [Related]
44. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation.
Suzawa M; Tamura Y; Fukumoto S; Miyazono K; Fujita T; Kato S; Takeuchi Y
J Bone Miner Res; 2002 Feb; 17(2):240-8. PubMed ID: 11811554
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a bone morphogenetic protein-responsive Smad-binding element.
Kusanagi K; Inoue H; Ishidou Y; Mishima HK; Kawabata M; Miyazono K
Mol Biol Cell; 2000 Feb; 11(2):555-65. PubMed ID: 10679014
[TBL] [Abstract][Full Text] [Related]
46. Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.
Kahata K; Hayashi M; Asaka M; Hellman U; Kitagawa H; Yanagisawa J; Kato S; Imamura T; Miyazono K
Genes Cells; 2004 Feb; 9(2):143-51. PubMed ID: 15009097
[TBL] [Abstract][Full Text] [Related]
47. BMP-2/ALK3 and HGF signal in parallel to regulate renal collecting duct morphogenesis.
Gupta IR; Macias-Silva M; Kim S; Zhou X; Piscione TD; Whiteside C; Wrana JL; Rosenblum ND
J Cell Sci; 2000 Jan; 113 Pt 2():269-78. PubMed ID: 10633078
[TBL] [Abstract][Full Text] [Related]
48. Negative regulation of BMP/Smad signaling by Tob in osteoblasts.
Yoshida Y; Tanaka S; Umemori H; Minowa O; Usui M; Ikematsu N; Hosoda E; Imamura T; Kuno J; Yamashita T; Miyazono K; Noda M; Noda T; Yamamoto T
Cell; 2000 Dec; 103(7):1085-97. PubMed ID: 11163184
[TBL] [Abstract][Full Text] [Related]
49. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
50. Expression and activation of the BMP-signaling components in human fracture nonunions.
Kloen P; Doty SB; Gordon E; Rubel IF; Goumans MJ; Helfet DL
J Bone Joint Surg Am; 2002 Nov; 84(11):1909-18. PubMed ID: 12429748
[TBL] [Abstract][Full Text] [Related]
51. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
[TBL] [Abstract][Full Text] [Related]
52. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
53. Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins.
Monteiro RM; de Sousa Lopes SM; Korchynskyi O; ten Dijke P; Mummery CL
J Cell Sci; 2004 Sep; 117(Pt 20):4653-63. PubMed ID: 15331632
[TBL] [Abstract][Full Text] [Related]
54. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
Daly AC; Randall RA; Hill CS
Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
[TBL] [Abstract][Full Text] [Related]
56. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
57. Bone morphogenetic protein-2 and -4 limit the number of enteric neurons but promote development of a TrkC-expressing neurotrophin-3-dependent subset.
Chalazonitis A; D'Autréaux F; Guha U; Pham TD; Faure C; Chen JJ; Roman D; Kan L; Rothman TP; Kessler JA; Gershon MD
J Neurosci; 2004 Apr; 24(17):4266-82. PubMed ID: 15115823
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression.
Wan M; Shi X; Feng X; Cao X
J Biol Chem; 2001 Mar; 276(13):10119-25. PubMed ID: 11139569
[TBL] [Abstract][Full Text] [Related]
59. BMP signaling components are expressed in human fracture callus.
Kloen P; Di Paola M; Borens O; Richmond J; Perino G; Helfet DL; Goumans MJ
Bone; 2003 Sep; 33(3):362-71. PubMed ID: 13678778
[TBL] [Abstract][Full Text] [Related]
60. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts.
Nöth U; Tuli R; Seghatoleslami R; Howard M; Shah A; Hall DJ; Hickok NJ; Tuan RS
Exp Cell Res; 2003 Nov; 291(1):201-11. PubMed ID: 14597420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
